Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation

Author:

Imaeva A. E.1,Balanova Yu. A.1,Kontsevaya A. V.1,Kapustina A. V.1,Duplyakov D. V.2,Malysheva O. H.3,Osipova I. V.4,Petrichko T. A.5,Kropanin G. I.6,Kasimov R. A.7,Leon D. A.8,McKee M.9

Affiliation:

1. National Medical Research Center for Preventive Medicine. Petroverigsky per. 10, Moscow

2. Samara Regional Cardiology Clinic. Aerodromnaya ul. 43, Samara

3. Medical Information-Analytical Centre. Herzena ul. 49, Kirov

4. Altai State Medical University. Lenina prosp. 40, Barnaul

5. Postgraduate Institute for Public Health Workers. Krasnodarskaya ul. 9, Khabarovsk

6. Regional Center for Medical Prevention. Gubkina ul. 15V, Belgorod

7. Vologda Regional Center of Medical Preventive Care. Mira ul. 9, Vologda

8. London School of Hygiene and Tropical Medicine. Keppel Street, London WC1E 7HT; The University of Tromsø – The Arctic University of Norway. Hansen Hansen Road 18, Tromsø

9. London School of Hygiene and Tropical Medicine. Keppel Street, London WC1E 7HT

Abstract

Aim. To evaluate the availability and affordability of medicines used to treat of cardiovascular diseases (CVD) in several regions of the Russian Federation with different climatic, geographic, economic and demographic characteristics. Material and methods. The study was conducted in 6 regional capitals, chosen to differ in geographically, economically, and demographically. In each city, 5 pharmacies providing free medicines to certain categories of citizens (beneficiaries) and 5 private pharmacies serving anyone were selected at random. Medicine availability was assessed in all pharmacies, along with price only in the private pharmacies. Data were obtained for both original drug and appropriate generics. A list of 25 of the most frequently prescribed medicines for cardiovascular diseases was compiled. Results. Some general findings emerged. With the existence of a generic drug, the original drug was not available in the pharmacy supplying beneficiaries. Diuretics, as well as some ACE inhibitors, are not available in a number of pharmacies for beneficiaries. Enalapril in most licensed pharmacies is represented by generics, lisinopril in a number of cities is represented by both the original drug and generics. The presence of sartans was much lower than ACE inhibitors. Bisoprolol was most common beta-blocker. Calcium antagonists: if amlodipine was present in all licensed pharmacies, at list as generic, then nifedipine was not available in many licensed pharmacies. Among antiplatelet agents, aspirin was available in most pharmacies, and clopidogrel was mostly represented by generics. As for statins, only simvastatin could be found in almost all pharmacies. When analyzing the cost of drugs in licensed pharmacies, it was found that drugs containing furosemide are the cheapest among generics – about 17 rubles. The most expensive treatment with generics of rosuvastatin – about 4,374 rubles a month. The most expensive original medicine was also rosuvastatin – about 4,500 rubles for 30 tablets, the cheapest – the original drug of furosemide – about 35 rubles. On average, the cost of CVD treatment with major classes of drugs, including ACE inhibitor, beta-blocker, antiplatelet drug and statin, is 1,921.9 rubles per month. Conclusion. The basic cardiovascular medicines were characterized by a relatively high availability in 6 regions of the Russian Federation included in the analysis both by the criterion of the availability of drugs and by the criterion of the minimum price.

Publisher

Stolichnaya Izdatelskaya Kompaniyaizdat

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Shkolnikov V.M., Andreev E.M., McKee M., Leon D.A. Components and possible determinants of decrease in Russian mortality in 2004-2010. Demogr Res. 2013;28:917-50. doi:10.4054/Dem-Res.2013.28.32.

2. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459-544. doi:10.1016/S0140-6736(16)31012-1.

3. Schwalm J-D., McKee M., Huffman M.D., Yusuf S. Resource Effective Strategies to Prevent and Treat Cardiovascular Disease. Circulation. 2016;133(8):742-55. doi:10.1161/CIRCULATIONAHA. 115.008721.

4. Khatib R., McKee M., Shannon H. et al. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: An analysis of the PURE study data. Lancet. 2016;387(10013):61-9. doi:10.1016/S0140-6736(15)00469-9.

5. Popovich L., Potapchik E., Shishkin S. et al. Russian Federation. Health system review. Health Syst Transit. 2011;13 (7):1-190 xiii – xiv.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3